TITLE

Cannabis as a substitute for prescription drugs - a cross-sectional study

AUTHOR(S)
Corroon, James M.; Mischley, Laurie K.; Sexton, Michelle
PUB. DATE
May 2017
SOURCE
Journal of Pain Research;May2017, Vol. 10, p989
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The use of medical cannabis is increasing, most commonly for pain, anxiety and depression. Emerging data suggest that use and abuse of prescription drugs may be decreasing in states where medical cannabis is legal. The aim of this study was to survey cannabis users to determine whether they had intentionally substituted cannabis for prescription drugs. Methods: A total of 2,774 individuals were a self-selected convenience sample who reported having used cannabis at least once in the previous 90 days. Subjects were surveyed via an online anonymous questionnaire on cannabis substitution effects. Participants were recruited through social media and cannabis dispensaries in Washington State. Results: A total of 1,248 (46%) respondents reported using cannabis as a substitute for prescription drugs. The most common classes of drugs substituted were narcotics/opioids (35.8%), anxiolytics/benzodiazepines (13.6%) and antidepressants (12.7%). A total of 2,473 substitutions were reported or approximately two drug substitutions per affirmative respondent. The odds of reporting substituting were 4.59 (95% confidence interval [CI], 3.87-5.43) greater among medical cannabis users compared with non-medical users and 1.66 (95% CI, 1.27-2.16) greater among those reporting use for managing the comorbidities of pain, anxiety and depression. A slightly higher percentage of those who reported substituting resided in states where medical cannabis was legal at the time of the survey (47% vs. 45%, p=0.58), but this difference was not statistically significant. Discussion: These patient-reported outcomes support prior research that individuals are using cannabis as a substitute for prescription drugs, particularly, narcotics/opioids, and independent of whether they identify themselves as medical or non-medical users. This is especially true if they suffer from pain, anxiety and depression. Additionally, this study suggests that state laws allowing access to, and use of, medical cannabis may not be influencing individual decisionmaking in this area.
ACCESSION #
123486677

 

Related Articles

  • Combination therapy more effectively induces remission of major depressive disorder.  // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2010, Vol. 23 Issue 6, p53 

    The article reports on a study which found that combination therapy with mirtazapine and other antidepressant medications is more effective than just fluoxetine for achieving remission of major depression.

  • Dogs Going to Pot? STRAUS, MARY // Whole Dog Journal;Apr2013, Vol. 16 Issue 4, p3 

    The article discusses legalization of medical marijuana in U.S. states as a concern for veterinarians. It notes that toxicity in dogs can be caused by marijuana ingestion. Veterinarians are advised to be able to recognize the signs of marijuana toxicosis. It also reveals the potential benefits...

  • Using Integrative Yoga Therapeutics in the Treatment of Comorbid Anxiety and Depression. Forbes, Bo; Akturk, Ceylan; Cummer-Nacco, Clementine; Gaither, Pam; Gotz, James; Harper, Alice; Hartsell, Katherine // International Journal of Yoga Therapy;2008, Issue 18, p87 

    This article describes the symptoms, causes, and treatments for anxiety, depression, and comorbid anxiety and depression. It provides strategies for addressing the hyper-arousal or hypo-arousal of the nervous system that is commonly associated with anxiety and depression. It explores research...

  • Doxepin (Depression, Anxiety).  // AHFS Consumer Medication Information;Sep2020, p1 

    Doxepin is used to treat depression and anxiety. Doxepin is in a class of medications called tricyclic antidepressants. It works by increasing the amounts of certain natural substances in the brain that are needed for mental balance.

  • A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Young, J.P.R; Hughes, W.C.; Lader, M.H. // British Medical Journal;5/8/1976, Vol. 1 Issue 6018, p1116 

    Investigates the amitriptyline or flupenthixol treatment on depressed patients under double-blind procedures. Consideration on the treatment procedures; Developments on patients after treatments; Absence of distinct characteristics of drug effectivity.

  • THE INTEGRATIVE MD ON... Are there really medical benefits from marijuana? WEIL, ANDREW // Prevention;Oct2015, Vol. 67 Issue 10, p127 

    The author tells that cannabinoids, the active compound in marijuana has medical use and many states in the United States have legalized medical marijuana though federal government has not approved the same.

  • Medical Marijuana Landscape Has Evolved Dramatically Over Past Decade. AHC MEDIA // Same-Day Surgery;Feb2020, Vol. 44 Issue 2, pN.PAG 

    Cannabis use is ubiquitous across the nation as states continue to legalize marijuana, both for medicinal and personal uses. Surgery patients who ingest the drug are at a higher risk of complications, which is why surgery center directors and physicians should understand legal, medical, and...

  • Pharmacological means to improve patients' mood. Are they effective and safe? Zylicz, Zbigniew Ben // Medycyna Paliatywna w Praktyce;2016, Vol. 10 Issue 4, p155 

    Low mood and depression can be treated with many non-pharmacological means. However, in terminally ill these means are sometimes insufficient and the doctors need to prescribe drugs. In this article I shall discuss simple and proven drugs that improve patients mood and, some of them do have...

  • Doxepin Hydrochloride.  // Annals of Internal Medicine;Sep74, Vol. 81 Issue 3, p360 

    Focuses on the use of doxepin hydrochloride for treating anxiety and depression. Reasons for the limited acceptance of the drug; List of other types of antianxiety and antidepressive drugs; Clinical studies on the effects of doxepin.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics